CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected By The Pandemic
RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA: CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package + template and Data Surveillance solution is being utilized in over 200 ongoing studies that […]
EPS Corporation Signs Groundbreaking Agreement To Drive Increased Quality And Safety Using CluePoints RBQM Solution
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a […]
CluePoints Launches Complimentary COVID-19 Risk Management Package For Clinical Studies
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that it has launched a complimentary COVID-19 risk management package and template available to all at no cost. With the FDA, EMA, PMDA and MHRA […]
Webinar Recording: The Critical Importance Of Early Risk Detection With A Special Feature Addressing COVID-19
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the Webinar The clinical research industry is in the midst of adopting Risk-Based Quality Management (RBQM) as a primary method for managing quality. RBQM encourages less reliance on traditional on-site monitoring including 100% source data verification/review (SDV/SDR), and greater reliance on centralized […]
CluePoints’ Central Statistical Monitoring Supports Business Continuity As Coronavirus Impacts Clinical Trial Operations
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the adoption of modern clinical trial technologies King of Prussia, PA: CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, has seen a dramatic increase in demand for remote and centralized site monitoring amid the ongoing […]
CluePoints’ Risk-Based Quality Management (RBQM) Software Wins At Scrip Awards 2019
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, today announced that it has been awarded best technological development in clinical trials in the 2019 Scrip Awards. CluePoints’ Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software was recognized for the essential role it plays in […]
As Demand For RBx Soars CluePoints Continues Global Expansion Alongside Further Award Wins
KING OF PRUSSIA, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced major expansion as it bolsters its offering with two new larger offices to accommodate its growing family of employees and contractors. This coincides with another distinction which saw CluePoints scoop Scale up of the Year […]
FDA Extends CRADA With CluePoints To Further Explore A Data-Driven Approach To Quality Oversight In Clinical Trials
KING OF PRUSSIA, PA– FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research. Misconduct in clinical research, including, but not limited to the falsification or omission of data in reporting research results, places all subjects in that trial […]
ICH E6 (R2) Compliance Webinar Series Available To Watch Now!
“I KNOW ICH E6 (R2) COMPLIANCE INSISTS ON A RISK-BASED APPROACH TO RUNNING MY TRIALS, BUT HOW AM I GOING TO IMPLEMENT THIS AND REALIZE THE VALUE?” This is the question on everyone’s mind and one that we’ve addressed many times with Sponsors & CROs. This comprehensive two-part on-demand webinar series answers all the questions […]
Parexel Strengthens Risk-Based Monitoring Offering With CluePoints’ New Advanced Statistical Capabilities
Strategic collaboration leverages CluePoints’ Central Statistical Monitoring (CSM) technology to enhance data quality and reduce operational costs. WAYNE, PA, June 18, 2019– Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today announced its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution […]
